Athanassios Sambanis - Publications

Affiliations: 
Biomedical Engineering Georgia Institute of Technology, Atlanta, GA 
Area:
Biomedical Engineering
Website:
https://www.chbe.gatech.edu/people/athanassios-sambanis

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Muthyala S, Safley S, Gordan K, Barber G, Weber C, Sambanis A. The effect of hypoxia on free and encapsulated adult porcine islets-an in vitro study. Xenotransplantation. 24. PMID 28247506 DOI: 10.1111/Xen.12275  0.307
2017 Thulé PM, Lin Y, Jia D, Olson DE, Tang SC, Sambanis A. mRNA destabilization improves glycemic responsiveness of transcriptionally regulated hepatic insulin gene therapy in vitro and in vivo. The Journal of Gene Medicine. PMID 28181342 DOI: 10.1002/Jgm.2946  0.615
2015 Chen T, Yuan J, Duncanson S, Hibert ML, Kodish BC, Mylavaganam G, Maker M, Li H, Sremac M, Santosuosso M, Forbes B, Kashiwagi S, Cao J, Lei J, Thomas M, ... ... Sambanis A, et al. Alginate encapsulant incorporating CXCL12 supports long-term allo- and xenoislet transplantation without systemic immune suppression. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 618-27. PMID 25693473 DOI: 10.1111/Ajt.13049  0.338
2015 Tiernan AR, Champion JA, Sambanis A. Trichostatin A affects the secretion pathways of beta and intestinal endocrine cells. Experimental Cell Research. 330: 212-21. PMID 25305500 DOI: 10.1016/J.Yexcr.2014.09.031  0.518
2014 Tiernan AR, Sambanis A. Bioluminescence tracking of alginate micro-encapsulated cell transplants. Journal of Tissue Engineering and Regenerative Medicine. PMID 25047413 DOI: 10.1002/Term.1946  0.467
2014 Tiernan AR, Thulé PM, Sambanis A. Therapeutic effects of a non-β cell bioartificial pancreas in diabetic mice. Transplantation. 98: 507-13. PMID 24926830 DOI: 10.1097/Tp.0000000000000247  0.49
2013 Ahmad HF, Sambanis A. Cryopreservation effects on recombinant myoblasts encapsulated in adhesive alginate hydrogels. Acta Biomaterialia. 9: 6814-22. PMID 23499987 DOI: 10.1016/J.Actbio.2013.03.002  0.735
2013 Duncanson S, Sambanis A. Dual factor delivery of CXCL12 and Exendin-4 for improved survival and function of encapsulated beta cells under hypoxic conditions. Biotechnology and Bioengineering. 110: 2292-300. PMID 23436382 DOI: 10.1002/Bit.24872  0.447
2013 Sambanis A. Bioartificial Pancreas Principles of Tissue Engineering: Fourth Edition. 849-868. DOI: 10.1016/B978-0-12-398358-9.00042-2  0.364
2012 Landázuri N, Levit RD, Joseph G, Ortega-Legaspi JM, Flores CA, Weiss D, Sambanis A, Weber CJ, Safley SA, Taylor WR. Alginate microencapsulation of human mesenchymal stem cells as a strategy to enhance paracrine-mediated vascular recovery after hindlimb ischaemia. Journal of Tissue Engineering and Regenerative Medicine. PMID 23281223 DOI: 10.1002/Term.1680  0.363
2012 Sambanis A. Encapsulated cell systems: the future of insulin delivery? Therapeutic Delivery. 3: 1028-32. PMID 23035589 DOI: 10.4155/tde.12.88  0.345
2012 Ahmad HF, Simpson NE, Lawson AN, Sambanis A. Cryopreservation effects on intermediary metabolism in a pancreatic substitute: a (13)C nuclear magnetic resonance study. Tissue Engineering. Part A. 18: 2323-31. PMID 22697373 DOI: 10.1089/Ten.Tea.2011.0702  0.716
2012 Lawson A, Mukherjee IN, Sambanis A. Mathematical modeling of cryoprotectant addition and removal for the cryopreservation of engineered or natural tissues. Cryobiology. 64: 1-11. PMID 22142903 DOI: 10.1016/J.Cryobiol.2011.11.006  0.778
2012 Durvasula K, Thulé PM, Sambanis A. Combinatorial insulin secretion dynamics of recombinant hepatic and enteroendocrine cells. Biotechnology and Bioengineering. 109: 1074-82. PMID 22094821 DOI: 10.1002/Bit.24373  0.521
2012 Sambanis A, Tan SA. Quantitative modeling of limitations caused by diffusion. Methods in Molecular Medicine. 18: 595-605. PMID 21370205 DOI: 10.1385/0-89603-516-6:595  0.31
2011 Goh F, Long R, Simpson N, Sambanis A. Dual perfluorocarbon method to noninvasively monitor dissolved oxygen concentration in tissue engineered constructs in vitro and in vivo. Biotechnology Progress. 27: 1115-25. PMID 21608139 DOI: 10.1002/Btpr.619  0.403
2011 Goh F, Sambanis A. In vivo noninvasive monitoring of dissolved oxygen concentration within an implanted tissue-engineered pancreatic construct. Tissue Engineering. Part C, Methods. 17: 887-94. PMID 21486202 DOI: 10.1089/Ten.Tec.2011.0098  0.397
2011 Lawson A, Ahmad H, Sambanis A. Cytotoxicity effects of cryoprotectants as single-component and cocktail vitrification solutions. Cryobiology. 62: 115-22. PMID 21262212 DOI: 10.1016/J.Cryobiol.2011.01.012  0.618
2011 Nerem RM, Sambanis A. Tissue engineering: from biology to biological substitutes. Tissue Engineering. 1: 3-13. PMID 19877911 DOI: 10.1089/Ten.1995.1.3  0.412
2010 Goh F, Gross JD, Simpson NE, Sambanis A. Limited beneficial effects of perfluorocarbon emulsions on encapsulated cells in culture: experimental and modeling studies. Journal of Biotechnology. 150: 232-9. PMID 20804794 DOI: 10.1016/J.Jbiotec.2010.08.013  0.484
2009 Bara H, Thulé PM, Sambanis A. A cell-based approach for diabetes treatment using engineered non-beta cells. Journal of Diabetes Science and Technology. 3: 555-61. PMID 20144295 DOI: 10.1177/193229680900300321  0.786
2009 Bara H, Sambanis A. Development and characterization of a tissue engineered pancreatic substitute based on recombinant intestinal endocrine L-cells. Biotechnology and Bioengineering. 103: 828-34. PMID 19280668 DOI: 10.1002/Bit.22284  0.802
2009 Constantinidis I, Grant SC, Simpson NE, Oca-Cossio JA, Sweeney CA, Mao H, Blackband SJ, Sambanis A. Use of magnetic nanoparticles to monitor alginate-encapsulated betaTC-tet cells. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 61: 282-90. PMID 19165877 DOI: 10.1002/Mrm.21833  0.403
2009 Stabler CL, Fraker C, Pedraza E, Constantinidis I, Sambanis A. Modeling and in vitro and in vivo characterization of a tissue engineered pancreatic substitute Journal of Combinatorial Optimization. 17: 54-73. DOI: 10.1007/S10878-008-9183-8  0.478
2008 Mukherjee IN, Li Y, Song YC, Long RC, Sambanis A. Cryoprotectant transport through articular cartilage for long-term storage: experimental and modeling studies. Osteoarthritis and Cartilage / Oars, Osteoarthritis Research Society. 16: 1379-86. PMID 18539055 DOI: 10.1016/J.Joca.2008.03.027  0.737
2008 Bara H, Sambanis A. Insulin-secreting L-cells for the treatment of insulin-dependent diabetes. Biochemical and Biophysical Research Communications. 371: 39-43. PMID 18406351 DOI: 10.1016/J.Bbrc.2008.03.154  0.787
2008 Ahmad HF, Stucky AN, Mukherjee IN, Song YC, Sambanis A. 69. Developing optimized vitrification protocols for a tissue-engineered pancreatic substitute Cryobiology. 57: 329. DOI: 10.1016/J.Cryobiol.2008.10.070  0.743
2007 Abruzzo T, Tun T, Sambanis A. Efficient transmicrocatheter delivery of functional fibroblasts with a bioengineered collagen gel-platinum microcoil complex: Toward the development of endovascular cell therapy for cerebral aneurysms American Journal of Neuroradiology. 28: 1586-1593. PMID 17846217 DOI: 10.3174/Ajnr.A0593  0.378
2007 Gross JD, Long RC, Constantinidis I, Sambanis A. Monitoring of dissolved oxygen and cellular bioenergetics within a pancreatic substitute Biotechnology and Bioengineering. 98: 261-270. PMID 17657780 DOI: 10.1002/Bit.21421  0.343
2007 Mukherjee IN, Song YC, Sambanis A. Cryoprotectant delivery and removal from murine insulinomas at vitrification-relevant concentrations. Cryobiology. 55: 10-8. PMID 17533114 DOI: 10.1016/J.Cryobiol.2007.04.002  0.761
2007 Gross JD, Constantinidis I, Sambanis A. Modeling of encapsulated cell systems Journal of Theoretical Biology. 244: 500-510. PMID 17049564 DOI: 10.1016/J.Jtbi.2006.08.012  0.491
2007 Stabler CL, Fraker C, Pedraza E, Constantinidis I, Sambanis A. Modeling and in vitro and in vivo characterization of a tissue engineered pancreatic substitute Aip Conference Proceedings. 953: 185-196. DOI: 10.1063/1.2817341  0.384
2006 Cheng SY, Constantinidis I, Sambanis A. Insulin secretion dynamics of free and alginate-encapsulated insulinoma cells. Cytotechnology. 51: 159-70. PMID 19002886 DOI: 10.1007/S10616-006-9025-4  0.711
2006 Constantinidis I, Simpson NE, Grant SC, Blackband SJ, Long RC, Sambanis A. Non-invasive monitoring of tissue-engineered pancreatic constructs by NMR techniques. Advances in Experimental Medicine and Biology. 585: 261-76. PMID 17120790 DOI: 10.1007/978-0-387-34133-0_18  0.343
2006 Cheng SY, Constantinidis I, Sambanis A. Use of glucose-responsive material to regulate insulin release from constitutively secreting cells. Biotechnology and Bioengineering. 93: 1079-88. PMID 16440350 DOI: 10.1002/Bit.20817  0.693
2006 Mukherjee IN, Song YC, Sambanis A. 48. Cryopreservation of a cell encapsulated system Cryobiology. 53: 388. DOI: 10.1016/J.Cryobiol.2006.10.049  0.785
2006 Mukherjee IN, Sung J, Ahmad H, Sambanis A. 31. Apoptosis and stress protein expression in the cryopreservation of βTC-tet cells Cryobiology. 53: 380-381. DOI: 10.1016/J.Cryobiol.2006.10.032  0.744
2005 Mukherjee N, Chen Z, Sambanis A, Song Y. Effects of cryopreservation on cell viability and insulin secretion in a model tissue-engineered pancreatic substitute (TEPS). Cell Transplantation. 14: 449-56. PMID 16285253 DOI: 10.3727/000000005783982882  0.503
2005 Tang SC, Sambanis A, Sibley E. Proteasome modulating agents induce rAAV2-mediated transgene expression in human intestinal epithelial cells. Biochemical and Biophysical Research Communications. 331: 1392-400. PMID 15883029 DOI: 10.1016/J.Bbrc.2005.03.245  0.605
2005 Stabler CL, Long RC, Sambanis A, Constantinidis I. Noninvasive measurement of viable cell number in tissue-engineered constructs in vitro, using 1H nuclear magnetic resonance spectroscopy Tissue Engineering. 11: 404-414. PMID 15869419 DOI: 10.1089/Ten.2005.11.404  0.454
2005 Mukherjee IN, Song YC, Sambanis A. Characteristics of Btc tet cells for use in the cryopreservation of a model tissue engineered pancreatic substitute Aiche Annual Meeting, Conference Proceedings. 8370.  0.804
2004 Berglund JD, Nerem RM, Sambanis A. Incorporation of intact elastin scaffolds in tissue-engineered collagen-based vascular grafts. Tissue Engineering. 10: 1526-35. PMID 15588412 DOI: 10.1089/Ten.2004.10.1526  0.323
2004 Tang SC, Sambanis A. Differential rAAV2 transduction efficiencies and insulin secretion profiles in pure and co-culture models of human enteroendocrine L-cells and enterocytes. The Journal of Gene Medicine. 6: 1003-13. PMID 15352073 DOI: 10.1002/Jgm.587  0.681
2004 Cheng SY, Gross J, Sambanis A. Hybrid pancreatic tissue substitute consisting of recombinant insulin-secreting cells and glucose-responsive material. Biotechnology and Bioengineering. 87: 863-73. PMID 15334413 DOI: 10.1002/bit.20195  0.68
2004 Oca-Cossio J, Mao H, Khokhlova N, Kennedy CM, Kennedy JW, Stabler CL, Hao E, Sambanis A, Simpson NE, Constantinidis I. Magnetically labeled insulin-secreting cells. Biochemical and Biophysical Research Communications. 319: 569-75. PMID 15178444 DOI: 10.1016/J.Bbrc.2004.04.195  0.441
2004 Simpson NE, Stabler CL, Simpson CP, Sambanis A, Constantinidis I. The role of the CaCl2-guluronic acid interaction on alginate encapsulated betaTC3 cells. Biomaterials. 25: 2603-10. PMID 14751746 DOI: 10.1016/J.Biomaterials.2003.09.046  0.333
2004 Song YC, Chen ZZ, Mukherjee N, Lightfoot FG, Taylor MJ, Brockbank KG, Sambanis A. VITRIFICATION OF TISSUE ENGINEERED PANCREATIC SUBSTITUTE (TEPS) Transplantation. 78: 203. DOI: 10.1097/00007890-200407271-00531  0.322
2003 Sambanis A. Encapsulated islets in diabetes treatment. Diabetes Technology & Therapeutics. 5: 665-8. PMID 14511421 DOI: 10.1089/152091503322250686  0.491
2003 Tang SC, Sambanis A. Development of genetically engineered human intestinal cells for regulated insulin secretion using rAAV-mediated gene transfer. Biochemical and Biophysical Research Communications. 303: 645-52. PMID 12659868 DOI: 10.1016/S0006-291X(03)00399-1  0.693
2003 Tang SC, Sambanis A. Preproinsulin mRNA engineering and its application to the regulation of insulin secretion from human hepatomas. Febs Letters. 537: 193-7. PMID 12606056 DOI: 10.1016/S0014-5793(03)00121-2  0.662
2003 Berglund JD, Mohseni MM, Nerem RM, Sambanis A. A biological hybrid model for collagen-based tissue engineered vascular constructs. Biomaterials. 24: 1241-54. PMID 12527265 DOI: 10.1016/S0142-9612(02)00506-9  0.397
2002 Stabler CL, Sambanis A, Constantinidis I. Effects of alginate composition on the growth and overall metabolic activity of betaTC3 cells. Annals of the New York Academy of Sciences. 961: 130-3. PMID 12081881 DOI: 10.1111/J.1749-6632.2002.Tb03065.X  0.323
2002 Constantinidis I, Long R, Weber C, Safley S, Sambanis A. Non-Invasive monitoring of a bioartificial pancreas in vitro and in vivo. Annals of the New York Academy of Sciences. 944: 83-95. PMID 11797698 DOI: 10.1111/J.1749-6632.2001.Tb03825.X  0.334
2002 Cheng SY, Gross J, Sambanis A. Development of hybrid pancreatic constructs based on genetically engineered cells and glucose-responsive materials Third Smith and Nephew International Symposium - Translating Tissue Engineering Into Products. 108.  0.337
2002 Sambanis A. Tissue engineering a pancreatic substitute: Current status and future challenges Third Smith and Nephew International Symposium - Translating Tissue Engineering Into Products. 68.  0.351
2001 Murphy CL, Sambanis A. Effect of oxygen tension and alginate encapsulation on restoration of the differentiated phenotype of passaged chondrocytes Tissue Engineering. 7: 791-803. PMID 11749735 DOI: 10.1089/107632701753337735  0.366
2001 Abruzzo T, Cloft HJ, Shengelaia GG, Waldrop SM, Kallmes DF, Dion JE, Constantinidis I, Sambanis A. In vitro effects of transcatheter injection on structure, cell viability, and cell metabolism in fibroblast-impregnated alginate microspheres Radiology. 220: 428-435. PMID 11477247 DOI: 10.1148/Radiology.220.2.R01Au31428  0.396
2001 Stabler C, Wilks K, Sambanis A, Constantinidis I. The effects of alginate composition on encapsulated βTC3 cells Biomaterials. 22: 1301-1310. PMID 11336302 DOI: 10.1016/S0142-9612(00)00282-9  0.364
2000 Sambanis A. Engineering challenges in the development of an encapsulated cell system for treatment of type 1 diabetes Diabetes Technology and Therapeutics. 2: 81-89. PMID 11467326 DOI: 10.1089/152091599316784  0.474
2000 Papas KK, Long R.C. J, Constantinidis I, Sambanis A. Effects of short-term hypoxia on a transformed cell-based bioartificial pancreatic construct Cell Transplantation. 9: 415-422. PMID 10972340  0.404
2000 Long RC, Papas KK, Sambanis A, Constantinidis I. In Vitro Monitoring of Total Choline Levels in a Bioartificial Pancreas: 1H NMR Spectroscopic Studies of the Effects of Oxygen Level Journal of Magnetic Resonance. 146: 49-57. PMID 10968957 DOI: 10.1006/Jmre.2000.2112  0.311
2000 Simpson NE, Bennett LK, Papas KK, Sambanis A, Constantinidis I. Effects of pH on murine insulinoma βTC3 cells Biochemical and Biophysical Research Communications. 273: 937-941. PMID 10891351 DOI: 10.1006/Bbrc.2000.3022  0.355
1999 Papas KK, Long RC, Sambanis A, Constantinidis I. Development of a bioartificial pancreas: II. Effects of oxygen on long- term entrapped βTC3 cell cultures Biotechnology and Bioengineering. 66: 231-237. PMID 10578093 DOI: 10.1002/(Sici)1097-0290(1999)66:4<231::Aid-Bit4>3.0.Co;2-U  0.471
1999 Papas KK, Long RC, Sambanis A, Constantinidis I. Development of a bioartificial pancreas: I. Long-term propagation and basal and induced secretion from entrapped βTC3 cell cultures Biotechnology and Bioengineering. 66: 219-230. PMID 10578092 DOI: 10.1002/(Sici)1097-0290(1999)66:4<219::Aid-Bit3>3.0.Co;2-B  0.533
1999 Constantinidis I, Rask I, Long RC, Sambanis A. Effects of alginate composition on the metabolic, secretory, and growth characteristics of entrapped βTC3 mouse insulinoma cells Biomaterials. 20: 2019-2027. PMID 10535813 DOI: 10.1016/S0142-9612(99)00104-0  0.487
1997 Papas KK, Long RC, Constantinidis I, Sambanis A. Role of ATP and Pi in the mechanism of insulin secretion in the mouse insulinoma betaTC3 cell line The Biochemical Journal. 326. PMID 9307031  0.426
1997 Benson JP, Papas KK, Constantinidis I, Sambanis A. Towards the development of a bioartificial pancreas: Effects of poly-L- lysine on alginate beads with BTC3 cells Cell Transplantation. 6: 395-402. PMID 9258513 DOI: 10.1016/S0963-6897(97)00044-4  0.505
1997 Papas KK, Long R.C. J, Constantinidis I, Sambanis A. Role of ATP and P(i) in the mechanism of insulin secretion in the mouse insulinoma βTC3 cell line Biochemical Journal. 326: 807-814.  0.421
1996 Papas KK, Long RC, Constantinidis I, Sambanis A. Effects of oxygen on metabolic and secretory activities of βTC3 cells Biochimica Et Biophysica Acta - General Subjects. 1291: 163-166. PMID 8898878 DOI: 10.1016/0304-4165(96)00062-1  0.403
1996 Tziampazis E, Sambanis A. Engineering a normally responsive bioartificial pancreas based on glucose-hypersensitive cells Computers in Biology and Medicine. 26: 231-240. PMID 8725774 DOI: 10.1016/0010-4825(96)00002-9  0.497
1995 Tziampazis E, Sambanis A. Tissue engineering of a bioartificial pancreas: Modeling the cell environment and device function Biotechnology Progress. 11: 115-126. PMID 7766095 DOI: 10.1021/Bp00032A001  0.525
1995 Mukundan NE, Flanders PC, Constantinidis I, Papas KK, Sambanis A. Oxygen Consumption Rates of Free and Alginate-Entrapped βTC3 Mouse Insulinoma Cells Biochemical and Biophysical Research Communications. 210: 113-118. PMID 7741729 DOI: 10.1006/Bbrc.1995.1634  0.403
1995 Dyken-Young JJ, Sambanis A. Changes in metabolism and hormone trafficking during exposure of endocrine cells to elevated ammonium Cytotechnology. 17: 35-44. DOI: 10.1007/Bf00749219  0.539
1995 Constantinidis I, Sambanis A. Towards the development of artificial endocrine tissues: 31P NMR spectroscopic studies of immunoisolated, insulin-secreting AtT-20 cells Biotechnology and Bioengineering. 47: 431-443. DOI: 10.1002/Bit.260470404  0.535
1994 Sambanis A, Papas KK, Flanders PC, Long RC, Kang H, Constantinidis I. Towards the development of a bioartificial pancreas: Immunoisolation and NMR monitoring of mouse insulinomas Cytotechnology. 15: 351-363. PMID 7765950 DOI: 10.1007/Bf00762410  0.547
1994 Tziampazis E, Sambanis A. Modeling of cell culture processes Cytotechnology. 14: 191-204. PMID 7765590 DOI: 10.1007/Bf00749616  0.379
1994 Dyken JJ, Sambanis A. Ammonium selectively inhibits the regulated pathway of protein secretion in two endocrine cell lines Enzyme and Microbial Technology. 16: 90-98. PMID 7764613 DOI: 10.1016/0141-0229(94)90069-8  0.506
1993 Papas KK, Constantinidis I, Sambanis A. Cultivation of recombinant, insulin-secreting AtT-20 cells as free and entrapped spheroids Cytotechnology. 13: 1-12. PMID 7764602 DOI: 10.1007/Bf00749970  0.509
1992 Grampp GE, Sambanis A, Stephanopoulos GN. Use of regulated secretion in protein production from animal cells: an overview Advances in Biochemical Engineering/Biotechnology. 46: 35-62. PMID 1636482  0.544
1991 Sambanis A, Lodish HF, Stephanopoulos G. A model of secretory protein trafficking in recombinant AtT-20 cells Biotechnology and Bioengineering. 38: 280-295. DOI: 10.1002/Bit.260380310  0.556
1990 Sambanis A, Stephanopoulos G, Lodish HF. Multiple episodes of induced secretion of human growth hormone from recombinant AtT-20 cells Cytotechnology. 4: 111-119. PMID 1367038 DOI: 10.1007/Bf00365091  0.543
1990 Sambanis A, Stephanopoulos G, Sinskey AJ, Lodish HF. Use of regulated secretion in protein production from animal cells: An evaluation with the AtT-20 model cell line Biotechnology and Bioengineering. 35: 771-780. DOI: 10.1002/Bit.260350804  0.56
1989 Sambanis A, Fredrickson AG. Effect of addition of wall growth to a model of ciliate-bacterial interactions. Biotechnology and Bioengineering. 34: 875-81. PMID 18588176 DOI: 10.1002/Bit.260340619  0.534
1989 Sambanis A, Fredrickson AG. Effect of addition of wall growth to a model of ciliate-bacterial interactions Biotechnology and Bioengineering. 34: 875-881.  0.534
1988 Sambanis A, Fredrickson AG. Peristance of bacteria in the presence of viable, nonencysting, bacterivorous ciliates Microbial Ecology. 16: 197-211. DOI: 10.1007/BF02018914  0.516
1987 Sambanis A, Pavlou S, Fredrickson AG. Coexistence of bacteria and feeding ciliates: Growth of bacteria on autochthonous substrates as a stabilizing factor for coexistence. Biotechnology and Bioengineering. 29: 714-28. PMID 18576506 DOI: 10.1002/Bit.260290608  0.533
1987 Sambanis A, Fredrickson AG. Long-term studies of ciliate-bacterial interactions: Use of a chemostat fed with bacteria grown in a separate chemostat Journal of General Microbiology. 133: 1619-1630.  0.515
1987 Sambanis A, Pavlou S, Fredrickson AG. Coexistence of bacteria and feeding ciliates: Growth of bacteria on autochthonous substrates as a stabilizing factor for coexistence Biotechnology and Bioengineering. 29: 714-728.  0.51
1986 Sambanis A, Pavlou S, Fredrickson AG. Analysis of the dynamics of ciliate-bacterial interactions in a CSTR Chemical Engineering Science. 41: 1455-1469. DOI: 10.1016/0009-2509(86)85231-9  0.544
Show low-probability matches.